CLINICAL PROFILE OF PATIENTS WITH OSTEOPOROSIS TREATED WITH ZOLEDRONIC ACID

被引:0
|
作者
Tabti, E. [1 ]
机构
[1] Univ Tlemcen, Tilimsen, Algeria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P431
引用
收藏
页码:S268 / S269
页数:2
相关论文
共 50 条
  • [1] CLINICAL PROFILE OF PATIENTS WITH OSTEOPOROSIS TREATED WITH ZOLEDRONIC ACID
    Tabti, E.
    Drici, Z.
    Chiali, S.
    Bestaoui, H.
    Lounici, A.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S645 - S645
  • [2] CLINICAL PROFILE OF OSTEOPOROTIC PATIENTS TREATED WITH ZOLEDRONIC ACID
    Negadi, S. N.
    Tabti, E.
    Benabadji, S.
    Lounici, A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S349 - S349
  • [3] Analysis of zoledronic acid prescribing and profile of patients treated
    Pardo-Pastor, J.
    Modamio, P.
    Pardo, C.
    Lastra, C. F.
    Mas, P.
    Marino, E. L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 995 - 995
  • [4] Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
    Riesco Barcena, Carmen
    Ivorra Cortes, Jose
    Grau Garcia, Elena
    Leal Rodriguez, Samuel
    Gonzalez Puig, Luis
    Huaylla Quispe, Anderson Victor
    Munoz Martinez, Pablo Francisco
    Torrat Noves, Alba Maria
    Ramos Castro, Daniel
    Mas Sanchez, Laura
    Canovas Olmos, Ines
    Charia, Hikmat
    Martinez Cordellat, Isabel
    Najera Herranz, Carmen
    Negueroles Albuixech, Rosa
    Oller Rodriguez, Jose Eloy
    De la Rubia Navarro, Marta
    Tovar Sugranes, Ernesto
    Vicens Bernabeu, Elvira
    Alcantara Alvarez, Iago
    Villanueva Manez, Belen
    Roman Ivorra, Jose Andres
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3986 - 3988
  • [5] Study of Adverse Effect Profile of Parenteral Zoledronic Acid in Female Patients with Osteoporosis
    Kotian, Prem
    Boloor, Archith
    Sreenivasaw, Sushanth
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (01) : OC4 - OC6
  • [6] MODELING AND SIMULATION OF FRACTURE RISK IN JAPANESE OSTEOPOROSIS PATIENTS TREATED WITH ZOLEDRONIC ACID.
    Kasai, H.
    Mori, Y.
    Ose, A.
    Shiraki, M.
    Tanigawara, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S100 - S101
  • [7] Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis
    Kong, Li
    Zuo, Kai
    Ma, Long
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2020, 36 (07) : 1703 - 1707
  • [8] Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
    A. D. Anastasilakis
    S. A. Polyzos
    A. Gkiomisi
    Z. G. Saridakis
    D. Digkas
    I. Bisbinas
    G. T. Sakellariou
    A. Papatheodorou
    P. Kokkoris
    P. Makras
    Osteoporosis International, 2015, 26 : 2521 - 2527
  • [9] Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
    Anastasilakis, A. D.
    Polyzos, S. A.
    Gkiomisi, A.
    Saridakis, Z. G.
    Digkas, D.
    Bisbinas, I.
    Sakellariou, G. T.
    Papatheodorou, A.
    Kokkoris, P.
    Makras, P.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (10) : 2521 - 2527
  • [10] EFFECTS OF ZOLEDRONIC ACID ON BONE MINERAL DENSITY IN MOROCCAN PATIENTS WITH OSTEOPOROSIS TREATED FOR BREAST CANCER
    Assadi, R.
    Nassar, K.
    Janani, S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S340 - S341